3.8 Article

Glaucoma Medication Adherence 1 Year after the Support, Educate, Empower Personalized Glaucoma Coaching Program

Related references

Note: Only part of the references are listed.
Article Ophthalmology

The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma

Lyne Racette et al.

Summary: Emerging evidence suggests that during the COVID-19 pandemic, adherence to ocular hypotensive medication decreased and was related to patient resilience. Adherence was significantly worse in Black patients compared with White patients.

OPHTHALMOLOGY (2022)

Article Ophthalmology

Demographic, Clinical, and Psychosocial Predictors of Change in Medication Adherence in the Support, Educate, Empower Program

David J. Miller et al.

Summary: The purpose of this study was to investigate whether demographic, clinical, or psychosocial factors moderate the change in medication adherence in the SEE program for patients with glaucoma. The results showed that lower income, fewer glaucoma medications, and increased glaucoma-related distress were associated with greater improvements in medication adherence through the SEE program. These findings indicate that the SEE program can enhance glaucoma self-management even among patients with social and psychological barriers to medication adherence.

OPHTHALMOLOGY GLAUCOMA (2022)

Article Ophthalmology

Improved Glaucoma Medication Adherence in a Randomized Controlled Trial

Kelly W. Muir et al.

Summary: This study aimed to test the effectiveness of an intervention to improve glaucoma medication adherence. The results showed that a multifaceted intervention can significantly improve adherence to glaucoma medication.

OPHTHALMOLOGY GLAUCOMA (2022)

Article Ophthalmology

The Minimal Clinically Important Difference in Glaucoma Medication Adherence: Interviews of Glaucoma Experts

Ajay Kolli et al.

Summary: Poor adherence to glaucoma medications is associated with progressive vision loss. Many interventions have been tried to increase adherence, but the clinically significant level of increased adherence remains unknown. Through interviews with glaucoma experts, a hypothesized minimal clinically important difference (MCID) for glaucoma medication adherence of between 15-20% was suggested, taking into consideration factors such as cost of intervention and physician burden.

OPHTHALMIC RESEARCH (2021)

Article Ophthalmology

Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up

Paula Anne Newman-Casey et al.

OPHTHALMOLOGY (2015)

Article Public, Environmental & Occupational Health

Causes of vision loss worldwide, 1990-2010: a systematic analysis

Rupert R. A. Bourne et al.

LANCET GLOBAL HEALTH (2013)

Article Ophthalmology

Do adherence rates and glaucomatous visual field progression correlate?

Gemma C. M. Rossi et al.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2011)

Review Medicine, General & Internal

Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review

Gregory Reardon et al.

PATIENT PREFERENCE AND ADHERENCE (2011)

Article Medicine, General & Internal

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories

Bernard Vrijens et al.

BMJ-BRITISH MEDICAL JOURNAL (2008)

Article Endocrinology & Metabolism

Motivational interviewing improves weight loss in women with type 2 diabetes

Delia Smith West et al.

DIABETES CARE (2007)

Review Medicine, General & Internal

Interventions to enhance medication adherence in chronic medical conditions - A systematic review

Sunil Kripalani et al.

ARCHIVES OF INTERNAL MEDICINE (2007)

Review Medicine, General & Internal

Drug therapy - Adherence to medication

L Osterberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)